Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cellsJun Shimizu, Tatsuo Shioda, Yuka Yoshimura et al.|Scientific Reports|2022Cited by 48
The potential of COVID-19 patients’ sera to cause antibody-dependent enhancement of infection and IL-6 productionJun Shimizu, Tatsuo Shioda, Tadahiro Sasaki et al.|Scientific Reports|2021Cited by 25